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Abstract
Background: There are three childhood disruptive behavior disorders (DBDs), attention deficit hyperactivity
disorder (ADHD), oppositional defiant disorder (ODD), and conduct disorder (CD). The most common
comorbid disorder in ADHD is ODD. DSM-IV describes three ADHD subtypes: predominantly inattentive type
(ADHD-IA), predominantly hyperactive-impulsive type (ADHD-HI), and combined type (ADHD-C). Prior work
suggests that specific candidate genes are associated with specific subtypes of ADHD in China. Our previous
association studies between ADHD and functional polymorphisms of COMT and MAOA, consistently showed
the low transcriptional activity alleles were preferentially transmitted to ADHD-IA boys. Thus, the goal of the
present study is to test the hypothesis that COMT Val158Met and MAOA-uVNTR jointly contribute to the ODD
phenotype among Chinese ADHD boys.
Methods: 171 Chinese boys between 6 and 17.5 years old (mean = 10.3, SD = 2.6) with complete COMT
val158met and MAOA-uVNTR genotyping information were studied. We used logistic regression with genotypes
as independent variables and the binary phenotype as the dependent variable. We used p < 0.05 as the level of
nominal statistical significance. Bonferroni correction procedures were used to adjust for multiple comparisons.
Results: Our results highlight the potential etiologic role of COMT in the ADHD with comorbid ODD and its
predominately inattentive type in male Chinese subjects. ADHD with comorbid ODD was associated with
homozygosity of the high-activity Val allele, while the predominantly inattentive ADHD subtype was associated
with the low-activity Met allele. We found no evidence of association between the MAOA-uVNTR variant and
ADHD with comorbid ODD or the ADHD-IA subtype.
Conclusion: Our study of attention deficit hyperactivity disorder comorbid oppositional defiant disorder and its
predominately inattentive type highlights the potential etiologic role of COMT for ADHD children in China. But
we failed to observe an interaction between COMT and MAOA, which suggests that epistasis between COMT
and MAOA genes does not influence the phenotype of ADHD-IA with comorbid ODD in a clinical sample of
Chinese male subjects. To confirm our findings further studies with a larger number of subjects and healthy
controls are needed.
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Background
The three childhood disruptive behavior disorders
(DBDs), attention deficit hyperactivity disorder (ADHD),
oppositional defiant disorder (ODD), and conduct disor-
der (CD), are characterized by developmentally extreme
and impairing levels of distractibility, hyperactivity,
impulsivity, hostility, and aggression [1]. They account for
a significant number of child psychiatry referrals [2]. The
most common comorbid disorder in ADHD is ODD, with
our prior work reporting that 36.5% of children with
ADHD have ODD in a sample of Chinese outpatients [3].
DSM-IV for ADHD describes three subtypes: predomi-
nantly inattentive type (ADHD-IA), predominantly
hyperactive-impulsive type (ADHD-HI), and combined
type (ADHD-C), each with different characteristics and
correlates [1]. Although ADHD is characterized by core
symptoms (inattention, hyperactivity and impulsivity),
there is considerable heterogeneity in clinical features
among individuals with ADHD [4]. Some twin studies
have demonstrated that the transmission of inattentive
and hyperactive-impulsive symptoms is distinct [5,6].
With a heritability estimate of 0.76 [7], evidence that the
etiology of ADHD is partially due to genes is compelling.
The evidence that there may be genes associated with spe-
cific ADHD subtypes [6,8] supported the heterogeneity
inherent in the definition of ADHD. Research has found
that specific candidate genes are associated with specific
subtypes of ADHD in China. In our prior work, the Met
allele of COMT was over transmitted to ADHD boys, espe-
cially the ADHD-IA subtype, and the -697G allele and
haplotype -759C/-697G of HTR2C was significantly over
transmitted to ADHD-C probands [9-11].
Because there is evidence that the covariation between
ADHD, ODD, and CD is largely due to shared genetic
influences [12,13], it is likely that at least some genes are
related to general susceptibility to DBDs [13], and that
dopaminergic genes may influence all of the externalizing
disorders.
Monoamine neurotransmitters in the brain, including
dopamine (DA), noradrenalin (NE), and serotonin (5-
HT), are metabolized by two key enzymes, catechol-O-
methyltransferase (COMT) and monoamine oxidase
(MAO). These two enzymes are of interest in the study of
aggressive behavior in both animals and human subjects.
The human COMT gene on 22q11 contains a functional
polymorphism (Val158Met) affecting the activity of the
enzyme at body temperature [14,15]. The low-activity Met
allele results in slower inactivation of extracellular
dopamine within the brain, especially in prefrontal cortex
[15,16]. There are data showing gender-specific effects of
COMT Val158Met genetic polymorphism on measures of
cognitive function [17]. We have previously reported the
low enzyme activity COMT Met allele was preferentially
transmitted to ADHD boys but not girls [9]. Early-onset
antisocial behavior in a high risk clinical group is pre-
dicted by COMT Val158Met and birth weight, in which
children with the ValVal genotype were more susceptible
to the effects of lower birth weight, had more symptoms
of conduct disorder and more aggressive behaviors com-
pared with Met carriers [18,19], although one study gave
negative results [20].
The gene for monoamine oxidase A (MAOA) maps to
Xp11.23. The longer repeats (3.5R, 4R, and 5R) of a func-
tional polymorphism in the promoter region of the
MAOA gene consists of 30-bp upstream repeats (MAOA-
uVNTR). The long alleles have been shown to affect the
transcription of the gene three to four times more effi-
ciently than the shorter 3R allele [21,22]. Studies in both
humans and animal models have supported the involve-
ment of MAOA in the etiology of externalizing behaviors,
especially in males, including impulsivity and aggression
[23-26], and ADHD [27]. In our research group, Zhang et
al., found a significant preferential transmission of the 3R
allele of MAOA-uVNTR to ADHD among boys (P = 0.01),
and also the inattentive subtype of ADHD in boys (P =
0.02). Zhang et al. found no association between MAOA-
uVNTR and ADHD among boys comorbid with ODD.
Since our previous association studies between ADHD
clinical phenotypes and these two functional polymor-
phisms consistently showed the low transcriptional activ-
ity alleles were preferentially transmitted to the inattentive
subtype of ADHD in boys, and because these polymor-
phisms are all involved in the probable etiology of exter-
nalizing behaviors, the goal of the present study is to test
the hypothesis that COMT Val158Met and MAOA-uVNTR
jointly contribute to the phenotype of ADHD-IA with
comorbid oppositional defiant disorder (ODD) in a clin-
ical sample of Chinese male subjects.
Methods
Subjects
ADHD cases were recruited from the child psychiatric
clinics at Peking University Institute of Mental Health.
Those families who gave consent to participate in the
study underwent the assessment process. The study was
approved by the Ethics Committee of the Health Science
Center, Peking University. To be included in the study,
children had to meet three criteria: (1) meet Diagnostic
and Statistical Manual of Mental Disorders (DSM-IV) cri-
teria for ADHD[1], (2) have a full scale IQ above 85
according to the Wechsler Intelligence Scale for Chinese
Children [28], and (3) be from the male Han population.
The exclusion criteria were: cases with any evidence of
major neurological conditions or a primary diagnosis ofBehavioral and Brain Functions 2009, 5:8 http://www.behavioralandbrainfunctions.com/content/5/1/8
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schizophrenia, affective disorder, pervasive development
disorder, or epilepsy.
Assessments
Consensus diagnoses were made according to the Clinical
Diagnostic Interviewing Scale (CDIS) [29], a structured
interview based on the DSM-IV. The CDIS assesses behav-
ioral and emotional disorders during childhood, includ-
ing ADHD. The CDIS was translated into Chinese by our
group. This rating scale has good sensitivity (97.2%) and
specificity (100%) for ADHD. The test-retest reliability
and criterion validity were each 0.89. The inter-rater relia-
bility kappa coefficient was 0.74 (P < 0.01) [3]. The CDIS
assesses the three DSM-IV subtypes of ADHD: ADHD
inattentive type (ADHD-IA), ADHD hyperactive-impul-
sive type (ADHD-HI), and ADHD combined type
(ADHD-C). All the parents were interviewed by two psy-
chiatrists separately, including one senior psychiatrist.
Teachers completed Rutter's Scale to evaluate the chil-
dren's behaviors. Finally, consensus diagnoses were
assigned to all probands.
The intelligence quotient (IQ) of subjects was assessed
using the Chinese-Wechsler Intelligence Scale for Chil-
dren (C-WISC), a revised edition of the Wechsler Intelli-
gence Scale for Children-Revised (WISC-R), which was
standardized by Gong and Cai [28].
Genotyping
Genomic DNA was extracted from whole venous blood
using the protein-depositing method. The COMT
val158met (rs4680) was genotyped under conditions pre-
viously described [9]. The MAOA-uVNTR was genotyped
according to the protocols described previously [21].
Ambiguous or unidentifiable results were reamplified and
rescored. Samples that continued to amplify poorly were
eliminated from the study. All genotyping was blinded to
the subject's ADHD status and IQ score and all clinical
assessments were blinded to genotype status.
Statistics
We used logistic regression with genotypes as independ-
ent variables and the binary phenotype as the dependent
variable. We used p < 0.05 as the level of nominal statisti-
cal significance. Bonferroni correction procedures were
used to adjust for multiple comparisons.
Results
There were 171 Chinese boys between 6 and 17.5 years
old (mean = 10.3, SD = 2.6) with complete COMT
val158met and MAOA-uVNTR genotyping information.
ADHD-IA accounted for 53.2% of the sample, ADHD-C
39.8%, and ADHD-HI 7.0%. Many ADHD children also
met diagnostic criteria for other disorders: 32.7% had
comorbid ODD, 6.4% had comorbid CD, 13.4% had an
emotional disorder, 13.5% had a tic disorder, 10.5% had
an affective disorder, and 32.2% had a learning disability
(LD).
Frequency of allele and genotype
For the COMT Val158Met polymorphism, 171 ADHD
boys were successfully genotyped. The allele frequencies
were: Val allele 66.1%, Met 33.9%. The genotype frequen-
cies were: valval 42.7%, ValMet 46.8%, MetMet 10.5%.
For the MAOA-uVNTR, 185 ADHD boys were successfully
genotyped. The 1, 2 and 5 R alleles of MAOA-uVNTR were
rare. Therefore, four individuals who carried them (one
boy had the 1R allele, two boys had the 2R allele, and one
boy had the 5R allele) were excluded. Since the MAOA
gene is X-linked, males had only one allele. The alleles
were grouped as 3R and 4R in the males for statistical
analyses. The allele frequencies were: 3R allele 69.6%, 4R
30.4%. The genotype distributions of the COMT and
MAOA gene polymorphism were in Hardy-Weinberg
equilibrium (P > 0.05). The numbers of subjects in each
group are showed in table 1.
Association between COMT and ODD in ADHD Children
Based on the val158met genotypes, subjects were divided
into groups: 73 homozygous for the Val allele and 98 car-
riers of Met allele since the frequency of the metmet gen-
otype was rare. In the comparison of ADHD with and
without ODD, the valval genotype was more frequent
among children with ADHD and ODD compared with
those having ADHD only (x2 = 5.46. p = 0.019). No statis-
tically significant group differences were found for
MAOA-uVNTR (Table 2).
Gene-gene interaction between COMT and MAOA on 
ADHD phenotype
Logistic regression was used to assess the joint effects of
the COMT and MAOA genes on the risk for ODD. Table 3
shows that the effect of COMT Val158Met was significant
after partialing out the effects of MAOA-uVNTR (p =
0.021). The valval genotype increased the risk for ODD
2.2 (1/0.465) times more than the valmet/metmet geno-
types. The interaction effect was not significant. The effect
of COMT was significant when correcting for the two tests
of main effects (p = 0.042), but not when including the
interaction effect.
Table 1: The numbers of subjects in each category of ADHD
ADHD subtype with ODD without ODD total
ADHD -IA 20 (22.0%) 71 (78.0%) 91
ADHD -C, adhd-HI 36 (45.0%) 44 (55.0%) 80
total 56 115 171Behavioral and Brain Functions 2009, 5:8 http://www.behavioralandbrainfunctions.com/content/5/1/8
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Our previous study showed that COMT met allele and
MAOA 3R allele were preferentially transmitted to ADHD
boys but not girls, especially the ADHD-IA subtype. In this
study, binary logistic regression was used to assess the
cumulative and interactive effects of the COMT and
MAOA genes on the risk for ADHD subtypes. The depend-
ent factor was the ADHD phenotype with 1 = non ADHD-
IA subtype and 2 = ADHD-IA subtype, and the covariates
were the genotypes of COMT and MAOA. When compar-
ing the ADHD-IA cases with non ADHD-IA cases, Tables 4
shows that the effects of the COMT risk genotype were sig-
nificant after partialing out the effects of the MAOA geno-
type (p = 0.025). The valmet/metmet genotype affected
the ADHD-IA subtype 2.024 times more profoundly than
the valval genotype. There remained a statistically signifi-
cant difference when it was adjusted with Bonferroni
method (p = 0.050).
Discussion
Our results highlight the potential etiologic role of COMT
in the ADHD comorbid ODD and its predominately inat-
tentive type in male Chinese subjects. ADHD with comor-
bid ODD was associated with homozygosity of the high-
activity Val allele, while the predominantly inattentive
ADHD subtype was associated with the low-activity Met
allele.
Catechol-O-methyltransferase methylates released cate-
cholamines, including dopamine, as part of the catabolic
cascade of this neurotransmitter to homovanillic acid.
Two main COMT protein isoforms exist, the short, soluble
cytoplasmic (S-COMT) isoform predominates in most
assayed tissues [30], while a longer membrane bound
form (MB-COMT) is the major species in brain [31].
Although expressed widely, COMT appears to be a minor
player in dopamine clearance compared with neuronal
synaptic uptake by the dopamine transporter and subse-
quent monoamine oxidase (MAO) metabolism [32].
However, studies in rats, knockout mice, and monkeys
suggest that COMT is of particular importance for intrasy-
naptic dopamine regulation in the prefrontal cortex (PFC)
[33,16,34-36,15], where dopamine transporter expres-
sion is low [35]. Mesocortical dopamine inputs to the pre-
frontal cortex play a critical role in normal cognitive
processes, behavior, and motivation [37,38]. There
appears to be excessive transmission of the allele that pro-
duces more COMT activity and less PFC DA in some psy-
chiatric disorders, which would cause less efficient PFC
processing. [39-42]. There were data that indicated an
effect of the COMT Val158Met genetic polymorphism on
cognitive functions in childhood [43,17], which showed
gender-specific effects on measures of IQ and executive
function [17]. ADHD children who were homozygous for
the valine variant had significantly better sustained atten-
tion than those ADHD children possessing at least one
copy of the methionine variant [44].
The PFC has also been implicated in the etiology of
aggressive and antisocial behavior in children [45]. In the
study of Capsi et al. [19], ADHD subjects with the valval
genotype had more symptoms of conduct disorder, were
more aggressive, and were more likely to be convicted of
criminal offenses compared with methionine carriers.
Our present study also suggested a role for the Val variant
in ADHD boys comorbid with ODD. ODD and CD
seemed to be strongly and developmentally related [46].
Studies suggested that the onset of ODD symptoms may
be a possible first step toward a life course characterized
by the emergence of more serious antisocial and violent
acts for some children [47,48]. In a genetic linkage study,
Table 2: genotype frequency of COMT and MAOA between two phenotypes
ADHD with ODD (n = 56) ADHD without ODD (n = 115) X2 P
COMT ValVal 31 (55.4%) 42 (36.5%)
ValMet/MetMet 25 (44.6%) 73 (63.5%) 5.461 0.019
MAOA 3R 38 (67.9%) 81 (70.4%)
4R 18 (32.1%) 34 (29.6%) 0.118 0.731
Table 3: Logistic regression analysis of ADHD with and without 
ODD subtype
 S.E. Wald Test P OR
MAOA-uVNTR 0.109 0.357 0.090 0.764 1.113
COMT Val158Met -0.766 0.331 5.345 0.021 0.465
Interaction -0.006 0.724 0.000 0.994 0.994
constant 0.875 1.255 --- --- ---
Table 4: Logistic regression analysis of ADHD-I and non ADHD-I 
subtype
 S.E. Wald Test P OR
MAOA-uVNTR 0.019 0.339 0.003 0.956 1.019
COMT Val158Met 0.705 0.314 5.037 0.025 2.024
Interaction -0.902 0.679 1.767 0.184 0.406
constant -1.015 1.242 --- --- ---Behavioral and Brain Functions 2009, 5:8 http://www.behavioralandbrainfunctions.com/content/5/1/8
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Jain et al. [49] found that incorporating ODD and CD
into the definition of affected increased evidence for link-
age and implicated new chromosomal regions when com-
pared to analyses examining the broader ADHD
phenotype.
We found no evidence of association between the MAOA-
uVNTR variant and ADHD with comorbid ODD or the
ADHD-IA subtype in contrast with previous studies, in
which the short variant was found to be associated with
impulsivity, aggression, and ADHD with concurrent con-
duct disorder [50,51].
There were several limitations to this study that bear com-
ment and suggest future directions. First, the major limita-
tion of the study is the small number of individuals with
the subtypes of ADHD. Our results, although nominally
significant, were not significant after correcting for multi-
ple comparisons. Larger samples, closer to 1000 are
needed for more definitive results [52,53]. Second, we
focused the study only in male ADHD subjects consider-
ing gender differences, as our previous evidence for a sex-
ually dimorphic transmission of COMT Val158Met and
MAOA-uVNTR alleles to individuals with ADHD could be
a chance finding. Third, we performed the analyses in the
ADHD patients without comparing healthy controls,
which limits the generalization of these results. Finally,
ADHD or related disorders might be accounted for by
both genetic and environmental factors such as maternal
prenatal smoking or drinking suggested by previous stud-
ies [54,55].
Conclusion
In summary, our study of attention deficit hyperactivity
disorder comorbid oppositional defiant disorder and its
predominately inattentive type highlights the potential
etiologic role of COMT in a Chinese sample. But we failed
to observe an interaction between COMT and MAOA,
which suggests that epistasis between COMT and MAOA
does not influence the phenotype of ADHD-IA with
comorbid ODD in a clinical sample of Chinese male sub-
jects. To confirm our findings further studies with a larger
number of subjects and healthy controls are needed.
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